Walgreens Boots Alliance Inc (WBA) : Burgundy Asset Management Ltd. scooped up 198,663 additional shares in Walgreens Boots Alliance Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 11, 2016. The investment management firm now holds a total of 4,400,613 shares of Walgreens Boots Alliance Inc which is valued at $345.9 Million.Walgreens Boots Alliance Inc makes up approximately 3.62% of Burgundy Asset Management Ltd.’s portfolio.
Other Hedge Funds, Including , Azimuth Capital Management reduced its stake in WBA by selling 155 shares or 0.13% in the most recent quarter. The Hedge Fund company now holds 117,039 shares of WBA which is valued at $9.2 Million. Walgreens Boots Alliance Inc makes up approx 0.88% of Azimuth Capital Management’s portfolio.Alpha Cubed Investments reduced its stake in WBA by selling 4,109 shares or 26.96% in the most recent quarter. The Hedge Fund company now holds 11,130 shares of WBA which is valued at $874,929. Walgreens Boots Alliance Inc makes up approx 0.27% of Alpha Cubed Investments’s portfolio.Dixon Hubard Feinour Brown Incva reduced its stake in WBA by selling 152 shares or 0.69% in the most recent quarter. The Hedge Fund company now holds 21,968 shares of WBA which is valued at $1.7 Million. Walgreens Boots Alliance Inc makes up approx 0.57% of Dixon Hubard Feinour Brown Incva’s portfolio.Sivik Global Healthcare boosted its stake in WBA in the latest quarter, The investment management firm added 43,512 additional shares and now holds a total of 70,000 shares of Walgreens Boots Alliance Inc which is valued at $5.6 Million. Walgreens Boots Alliance Inc makes up approx 2.43% of Sivik Global Healthcare’s portfolio.Chatham Capital Group reduced its stake in WBA by selling 200 shares or 3.42% in the most recent quarter. The Hedge Fund company now holds 5,650 shares of WBA which is valued at $447,932. Walgreens Boots Alliance Inc makes up approx 0.14% of Chatham Capital Group’s portfolio.
Walgreens Boots Alliance Inc opened for trading at $78.41 and hit $79.23 on the upside on Monday, eventually ending the session at $78.87, with a gain of 0.33% or 0.26 points. The heightened volatility saw the trading volume jump to 52,09,229 shares. Company has a market cap of $85,199 M.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 5, 2016. Analyst had a consensus of $1.28. The company had revenue of $30184.00 million for the quarter, compared to analysts expectations of $30666.29 million. The company’s revenue was up 13.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by Barclays on Mar 10, 2016 to “Equal Weight” and Lowered the Price Target to $ 76 from a previous price target of $81 .Mizuho Upgraded Walgreens Boots Alliance Inc on Mar 1, 2016 to ” Buy”, Price Target of the shares are set at $90.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.